Back to Search Start Over

Vasculocentric Axonal NfH in Small Vessel Disease

Authors :
Adam Anad
Miriam K Barker
Jessica A Katanga
Konstantinos Arfanakis
Leslie R Bridges
Margaret M Esiri
Jeremy D Isaacs
Sonja Prpar Mihevc
Anthony C Pereira
Julie A Schneider
Atticus H Hainsworth
Source :
Journal of Neuropathology & Experimental Neurology. 81:182-192
Publication Year :
2022
Publisher :
Oxford University Press (OUP), 2022.

Abstract

Cerebral small vessel disease (SVD) causes lacunar stroke and vascular cognitive impairment in older people. The pathogenic pathways from vessel pathology to parenchymal damage in SVD are unknown. Neurofilaments are axonal structural proteins. Neurofilament-light (NfL) is an emerging biomarker for neurological disease. Here, we examined the high molecular weight form neurofilament-heavy (NfH) and quantified a characteristic pattern of peri-arterial (vasculocentric) NfH labeling. Subcortical frontal and parietal white matter from young adult controls, aged controls, and older people with SVD or severe Alzheimer disease (n = 52) was immunohistochemically labeled for hyperphosphorylated NfH (pNfH). The extent of pNfH immunolabeling and the degree of vasculocentric axonal pNfH were quantified. Axonal pNfH immunolabeling was sparse in young adults but a common finding in older persons (controls, SVD, or AD). Axonal pNfH was often markedly concentrated around small penetrating arteries. This vasculocentric feature was more common in older people with SVD than in those with severe AD (p = 0.004). We conclude that axonal pNfH is a feature of subcortical white matter in aged brains. Vasculocentric axonal pNfH is a novel parenchymal lesion that is co-located with SVD arteriopathy and could be a consequence of vessel pathology.

Details

ISSN :
15546578 and 00223069
Volume :
81
Database :
OpenAIRE
Journal :
Journal of Neuropathology & Experimental Neurology
Accession number :
edsair.doi.dedup.....00719e25c03042e5be1914b7a5441f85
Full Text :
https://doi.org/10.1093/jnen/nlab134